The Valley Desk

NCT00553644 · Interventional trial

Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Overall registry status Completed

Phase 2

Conditions Recurrent Mantle Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov